BioNTech #mRNA #CancerResearch #Biotechnology

BioNTech Halts mRNA Colorectal Cancer Vaccine Trial

BioNTech has decided to terminate a Phase 2 clinical trial testing its personalized mRNA cancer immunotherapy, autogene cevumeran, in patients…